Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Germany
since 2007 – Director, Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Germany
since 2007 – Full Professor (Cardiology/Adult Congenital Heart Disease), University of Muenster, Germany
1993 – 2007 Staff cardiologist, Dept. of Cardiology, Medical University – Vienna General Hospital
1993 – 2007 Professor of Medicine / Cardiology, Medical University of Vienna
1993 – 2007 Director, Adult Congenital Heart Disease and Acquired Valvular Heart Disease Program, Medical University of Vienna
1993 – 2007 Director, Research Program on Adult Congenital Heart Disease and Acquired Valvular Heart Disease, Medical University of Vienna
1993 – 2007 Director, In-Vitro Echocardiography Research Laboratory
1993 – 2001 Director, Echocardiography Laboratory, Dept. of Cardiology, Medical University of Vienna
1992 – 1993 Staff cardiologist and Director, Echocardiography Laboratory, 2nd Department of Internal Medicine / Cardiology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
1981 – 1983 Internship, Krankenhaus der Barmherzigen Schwestern , Linz and St. Pölten General Hospital, Austria
1994 – 1989 Residency/Fellowship, Internal Medicine; 1st and 2nd Dept. of Internal Medicine, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
1989 – 1990 Research Fellowship, Division of Cardiology, Cedars-Sinai Medical Center, University of California at Los Angeles, Los Angeles, USA
1990 – 1991 Clinical Fellowship in Cardiology; 2nd Dept. of Internal Medicine / Cardiology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
Clinical and basic research in the area of valvular heart disease and congenital heart disease
Clinical and experimental research in echocardiography
Catheter intervention in congenital and acquired valvular heart disease Myocardial viability
More than 250 publications, of these more than 150 papers in peer-reviewed journals
Medical Societies / Fellowships / Journals (selected)
Austrian Society of Cardiology: Chairman of the working group on adult congenital heart disease; President of the Society 2005-2007
European Society of Cardiology: Board member 2006-2008; Nucleus member of the working group on grown-up congenital heart disease, co-chairman 2004-2006, chairman 2006–2008, past-chairman 2008-2010, Chairman, TF Practice guidelines on the management of grown-up congenital heart disease, Task forces and committees (Practice guidelines on the management of valvular heart disease, Education committee, Accreditation committee), Clinical Practice Guidelines Committee (2010-2014),Congress Programme Committee (2010-2014)
A. John Camm
St. George’s University of London, UK
John Camm is Professor of Clinical Cardiology at St George’s Hospital Medical School, University of London, UK, and Imperial College, London.
Professor Camm’s interests include cardiac arrhythmias, atrial fibrillation, stroke prevention, anticoagulation, clinical cardiac electrophysiology, cardiac pacemakers, and risk stratification in post-myocardial infarction, heart failure and cardiomyopathy patients.
Professor Camm graduated from Guy’s Hospital, London and pursued a career in cardiology at St Bartholomew’s Hospital, London, before moving to St George’s in 1986. He was elected Chair of Medicine in October 1990. Professor Camm is a Fellow of the Royal College of Physicians (London, Edinburgh and Glasgow), The Academy of Medical Sciences, the American College of Cardiology, the American Heart Association, the Heart Rhythm Society, the European Society of Cardiology, the European Heart Rhythm Association. He is President of the Arrhythmia Alliance, Founder and Trustee of the Atrial Fibrillation Society, Trustee of the Drug Safety Research Unit, President of the European Heart Rhythm Society, Editor-in-Chief of European Heart Journal – Case Reports and Clinical Cardiology, Editor of the European Heart Journal, editorial board member of a further 15 journals, and Editor of the European Society of Cardiology Textbook of Cardiovascular Medicine and ESC CardioMed.
Professor Camm has been involved in the production of numerous guidelines, including the ESC guidelines for the management of atrial fibrillation and the NICE guidelines for the treatment of unstable angina and non-ST elevation ACS. He has authored or co-authored over 1300 papers.
Professor Camm is a recipient of several honours including Queen’s Honorary Physician for his work in setting up and contributing to the medical protection of the Queen and the Royal Family over a period of 25 years, and Commander of the Venerable Order of St. John of Jerusalem for his contribution to teaching and service in the St. John Ambulance Brigade.
Professor Camm is the recipient of the European Society of Cardiology Gold Medal and the British Cardiovascular Society Mackenzie Medal.
National Cardiovascular Institute and Slovak Medical University, Bratislava, Slovakia
Robert Hatala is Head of the Division of Cardiology at the National Cardiovascular Institute and Slovak Medical University in Bratislava, Slovakia.
Department of Internal Medicine and Cardiology, Saarland University Hospital, Homburg, Germany
Dr Felix Mahfoud studied medicine at the Johann-Wolfgang-Goethe University, Frankfurt, Germany. He completed his residency at the Department of Internal Medicine and Cardiology, Angiology and Intensive Care Medicine, Saarland University Hospital, Homburg, Germany. He is currently associate professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital and Affiliate/Visiting Professor of the Harvard-MIT, Biomedical Engineering, Boston, MA. Dr Mahfoud has board certifications in internal medicine, cardiology, intensive care medicine, and hypertension. He is a recipient of multiple national and international awards. His special scientific interest includes pathophysiology, conservative and novel interventional therapies of hypertension and heart failure. He is member of several editorial boards and serves as board member of the European Society of Cardiology Council on Hypertension‚ Vice-Chair of the Working Group Interventional Hypertension Treatment of the European Society of Hypertension, EuroPCR Board of Directors, Co-Chairmen of the Resistant Hypertension Course, and program committee member of the ESC congress 2017 & 2018. Dr Mahfoud is involved as steering committee member in the design and execution of several pharmaceutical and interventional studies in hypertension treatment.
King’s College London, King’s College Hospital, London, UK
In 2004 Professor Wendler was appointed at King’s College Hospital, and held the position of clinical director for cardiovascular services from 2006 until 2012, when he was promoted Professor of Cardiac Surgery at King’s College London.
Professor Wendler has a particular interests in the treatment of heart valve disease and is sub-specialised in valve repair techniques including the aortic root, mitral and tricuspid valve. Due to his particular expertise in this area, Professor Wendler runs a service particularly specialised in the treatment of complex multiple heart valve surgery including patients with carcinoid disease. Through his close collaboration with the vascular surgical department and interventional radiology he has also established King’s College Hospital as one of the major centers for thoracic aortic surgery.
In 2007 Professor Wendler performed the first transapical Transcatheter Aortic Valve Implantation (TAVI) in the UK and has established King’s College Hospital as one of the major international centers for this innovative treatment. Over recent years the King’s Heart Team performed the first TAVI in a failing aortic bioprosthesis (2008), the first transcatheter valve implantation in a failing mitral bioprosthesis (2010) and the worlds first non-predilation transapical TAVI in 2011.
Most recent developments of the King’s Heart Team focus on patients with ischemic cardiomyopathy and the treatment of patients with functional mitral regurgitation as a result of left ventricular dysfunction. The first minimal invasive surgery on a patient with a left ventricular aneurysm using the LIVE (Less Invasive Ventricular Enhancement) procedure was performed at King’s in 2013 and new minimally invasive treatment for mitral regurgitation is awaited soon.